The global pharmaceutical manufacturing market size is expected to reach USD 957.59 billion by 2028, registering a CAGR of 11.34% over the forecast years, according to a new report by Grand View Research, Inc. The presence of supportive regulatory legislations, patentability norms, and high funding and investments in the pharmaceutical industry are anticipated to drive market growth. In addition, the broadening of preventive care has created significant opportunities in the market.
The high burden of diseases, economic growth leading to a rise in disposable incomes, improvements in healthcare infrastructure, better healthcare financing, and a rise in the geriatric population have spurred the demand for pharmaceutical manufacturing techniques in biotechnology and pharmaceutical companies. These factors have also prompted many individuals to use medications to improve their quality of life and wellness. In addition, the emergence of new pandemics, viruses, and drug-resistant infections has provided potential avenues for pharmaceutical manufacturers to accelerate their drug production.
Several drug developers have shifted their preferences towards continuous manufacturing approaches to minimize production costs, overcome medicine shortages, and improve efficiencies. For instance, in March 2021, CONTINUUS Pharmaceuticals announced the construction of the first GMP facility using continuous manufacturing equipment. The company has received a contract from the U.S. government for the production of finished dosage forms and critical APIs. North America accounted for the highest revenue share in 2029 as the U.S. market represents the largest pharmaceutical industry with a substantial number of drug manufacturers.
Request a free sample copy or view report summary: Pharmaceutical Manufacturing Market Report
Conventional drug manufacturing captured a significant revenue share in 2020 owing to the high penetration of small molecules in terms of usage. An increasing number of regulatory approvals has also positively impacted the segment growth
Outsource drug development accounted for the largest revenue share in 2020 due to continuous efforts undertaken by the key service providers to expand their production capacities
The Over-the-Counter (OTC) medicines segment is anticipated to grow at the fastest CAGR from 2021 to 2028 due to the continuous transition from prescription to OTC. This shift from prescription medicines to OTC medicines has potentially benefitted the patients both financially and in terms of better health
The children & adolescents segment is expected to grow at the fastest CAGR from 2021 to 2028 due to the presence of supportive government initiatives that encourage pediatric studies. The Pediatric Research Equity Act and Best Practices for Children Act are among the few initiatives of the FDA that focus on the development of drugs for children
The retail sale channel segment held the maximum revenue share as a large percentage of individuals use a retail pharmacy as their one-stop-shop for pharmaceutical products
Grand View Research has segmented the global pharmaceutical manufacturing market on the basis of molecule type, drug development type, formulation, routes of administration, therapy area, prescription, age group, sales channel, and region:
Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Billion, 2018 - 2028)
Biologics & Biosimilars (Large Molecules)
Conventional Drugs (Small Molecules)
Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Billion, 2018 - 2028)
Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Billion, 2018 - 2028)
Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Billion, 2018 - 2028)
Other Routes of Administration
Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Billion, 2018 - 2028)
Cardiovascular Diseases (CVDs)
Pharmaceutical Manufacturing Prescription Outlook (Revenue, USD Billion, 2018 - 2028)
Over-the-counter (OTC) Medicines
Pharmaceutical Manufacturing Age Group Outlook (Revenue, USD Billion, 2018 - 2028)
Children & Adolescents
Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Billion, 2018 - 2028)
Pharmaceutical Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2028)
Middle East Africa (MEA)
List of Key Players of Pharmaceutical Manufacturing Market
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.; Merck & Co., Inc.
Johnson & Johnson
Eli Lilly and Company
Sun Pharmaceutical Industries Ltd.
Novo Nordisk A/S
Takeda Pharmaceuticals, Inc.
Bristol Myers Squibb Company
Gilead Sciences, Inc.
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."